$MGYR
Magyar Bancorp, Inc.

2023 Q3 Form 10-Q Financial Statement

#000117494723001034 Filed on August 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $9.777M
YoY Change 30.78%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $212.0K $210.0K
YoY Change 0.0% 0.0%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense $2.887M
YoY Change 463.87%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $2.859M $2.706M
YoY Change -16.62% -9.89%
Income Tax $674.0K $788.0K
% Of Pretax Income 23.57% 29.12%
Net Earnings $2.185M $1.918M
YoY Change -10.08% -9.4%
Net Earnings / Revenue 19.62%
Basic Earnings Per Share $0.30
Diluted Earnings Per Share $0.34 $0.30
COMMON SHARES
Basic Shares Outstanding 6.662M shares 6.689M shares
Diluted Shares Outstanding 6.413M shares

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $72.53M $22.40M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $13.34M $13.48M
YoY Change -3.9% -3.35%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $907.3M $857.4M
YoY Change 13.62% 8.45%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $11.10M $11.80M
YoY Change 14.73% 62.58%
Accrued Expenses $2.944M
YoY Change -18.34%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $14.04M $11.80M
YoY Change 5.75% 7.01%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $14.04M $11.80M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $802.5M $754.7M
YoY Change 14.64% 9.43%
SHAREHOLDERS EQUITY
Retained Earnings $52.17M $50.18M
YoY Change 13.97% 15.24%
Common Stock $71.00K $71.00K
YoY Change -99.89% -99.89%
Preferred Stock
YoY Change
Treasury Stock (at cost) $5.362M $5.478M
YoY Change -7.44% 341.06%
Treasury Stock Shares
Shareholders Equity $104.8M $102.8M
YoY Change
Total Liabilities & Shareholders Equity $907.3M $857.4M
YoY Change 13.62% 8.45%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income $2.185M $1.918M
YoY Change -10.08% -9.4%
Depreciation, Depletion And Amortization $212.0K $210.0K
YoY Change 0.0% 0.0%
Cash From Operating Activities $3.931M $340.0K
YoY Change -14.89% -91.13%
INVESTING ACTIVITIES
Capital Expenditures $68.00K $100.0K
YoY Change -148.23% -217.65%
Acquisitions
YoY Change
Other Investing Activities $1.193M -$20.80M
YoY Change -136.96% 55.1%
Cash From Investing Activities $1.125M -$20.90M
YoY Change -133.39% 54.86%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 45.07M 17.53M
YoY Change 1239.44% -190.75%
NET CHANGE
Cash From Operating Activities 3.931M 340.0K
Cash From Investing Activities 1.125M -20.90M
Cash From Financing Activities 45.07M 17.53M
Net Change In Cash 50.13M -3.030M
YoY Change 986.2% -89.54%
FREE CASH FLOW
Cash From Operating Activities $3.931M $340.0K
Capital Expenditures $68.00K $100.0K
Free Cash Flow $3.863M $240.0K
YoY Change -18.84% -93.88%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-51726
dei Entity Registrant Name
EntityRegistrantName
Magyar Bancorp, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-4154978
dei Entity Address Address Line1
EntityAddressAddressLine1
400 Somerset Street
dei Entity Address City Or Town
EntityAddressCityOrTown
New Brunswick
dei Entity Address State Or Province
EntityAddressStateOrProvince
NJ
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
08901
dei City Area Code
CityAreaCode
(732)
dei Local Phone Number
LocalPhoneNumber
342-7600
dei Security12b Title
Security12bTitle
Common Stock, $.01 per share
dei Trading Symbol
TradingSymbol
MGYR
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
6662098 shares
CY2023Q2 us-gaap Cash
Cash
3064000 usd
CY2022Q3 us-gaap Cash
Cash
2869000 usd
CY2023Q2 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
19340000 usd
CY2022Q3 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
28067000 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
22404000 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
30936000 usd
CY2023Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
8734000 usd
CY2022Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
9229000 usd
CY2023Q2 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
73337000 usd
CY2022Q3 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
79914000 usd
CY2023Q2 us-gaap Held To Maturity Securities Amortized Cost Before Other Than Temporary Impairment
HeldToMaturitySecuritiesAmortizedCostBeforeOtherThanTemporaryImpairment
83720000 usd
CY2022Q3 us-gaap Held To Maturity Securities Amortized Cost Before Other Than Temporary Impairment
HeldToMaturitySecuritiesAmortizedCostBeforeOtherThanTemporaryImpairment
91646000 usd
CY2023Q2 us-gaap Federal Home Loan Bank Stock
FederalHomeLoanBankStock
3051000 usd
CY2022Q3 us-gaap Federal Home Loan Bank Stock
FederalHomeLoanBankStock
1447000 usd
CY2023Q2 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
8378000 usd
CY2022Q3 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
8433000 usd
CY2023Q2 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
693308000 usd
CY2022Q3 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
619843000 usd
CY2023Q2 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
17938000 usd
CY2022Q3 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
17660000 usd
CY2023Q2 us-gaap Accrued Investment Income Receivable
AccruedInvestmentIncomeReceivable
4143000 usd
CY2022Q3 us-gaap Accrued Investment Income Receivable
AccruedInvestmentIncomeReceivable
3478000 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
13483000 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
13880000 usd
CY2023Q2 us-gaap Other Real Estate
OtherRealEstate
291000 usd
CY2022Q3 us-gaap Other Real Estate
OtherRealEstate
281000 usd
CY2023Q2 us-gaap Other Assets
OtherAssets
10377000 usd
CY2022Q3 us-gaap Other Assets
OtherAssets
10143000 usd
CY2023Q2 us-gaap Assets
Assets
857449000 usd
CY2022Q3 us-gaap Assets
Assets
798543000 usd
CY2023Q2 us-gaap Deposits
Deposits
693472000 usd
CY2022Q3 us-gaap Deposits
Deposits
667733000 usd
CY2023Q2 us-gaap Other Liabilities
OtherLiabilities
3907000 usd
CY2022Q3 us-gaap Other Liabilities
OtherLiabilities
3407000 usd
CY2023Q2 us-gaap Debt Current
DebtCurrent
45534000 usd
CY2022Q3 us-gaap Debt Current
DebtCurrent
15625000 usd
CY2023Q2 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
213000 usd
CY2022Q3 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
85000 usd
CY2023Q2 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
11566000 usd
CY2022Q3 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
13191000 usd
CY2023Q2 us-gaap Liabilities
Liabilities
754692000 usd
CY2022Q3 us-gaap Liabilities
Liabilities
700041000 usd
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000 shares
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000 shares
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
14000000 shares
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
14000000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7097825 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7097825 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6668572 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6745128 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
71000 usd
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
71000 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
63023000 usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
63734000 usd
CY2023Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
429253 shares
CY2022Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
465693 shares
CY2023Q2 us-gaap Treasury Stock Value
TreasuryStockValue
5478000 usd
CY2022Q3 us-gaap Treasury Stock Value
TreasuryStockValue
5793000 usd
CY2023Q2 mgyr Unearned Esop Shares Cost
UnearnedEsopSharesCost
3113000 usd
CY2022Q3 mgyr Unearned Esop Shares Cost
UnearnedEsopSharesCost
3169000 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
50182000 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
45773000 usd
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1928000 usd
CY2022Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2114000 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
102757000 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
98502000 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
857449000 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
798543000 usd
CY2023Q2 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
9033000 usd
CY2022Q2 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
7018000 usd
us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
25610000 usd
us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
20281000 usd
CY2023Q2 us-gaap Interest Income Securities Taxable
InterestIncomeSecuritiesTaxable
692000 usd
CY2022Q2 us-gaap Interest Income Securities Taxable
InterestIncomeSecuritiesTaxable
428000 usd
us-gaap Interest Income Securities Taxable
InterestIncomeSecuritiesTaxable
1707000 usd
us-gaap Interest Income Securities Taxable
InterestIncomeSecuritiesTaxable
1023000 usd
CY2023Q2 us-gaap Interest Income Securities Tax Exempt
InterestIncomeSecuritiesTaxExempt
14000 usd
CY2022Q2 us-gaap Interest Income Securities Tax Exempt
InterestIncomeSecuritiesTaxExempt
11000 usd
us-gaap Interest Income Securities Tax Exempt
InterestIncomeSecuritiesTaxExempt
43000 usd
us-gaap Interest Income Securities Tax Exempt
InterestIncomeSecuritiesTaxExempt
27000 usd
CY2023Q2 mgyr Federal Home Loan Bank Of New York Stock
FederalHomeLoanBankOfNewYorkStock
38000 usd
CY2022Q2 mgyr Federal Home Loan Bank Of New York Stock
FederalHomeLoanBankOfNewYorkStock
19000 usd
mgyr Federal Home Loan Bank Of New York Stock
FederalHomeLoanBankOfNewYorkStock
92000 usd
mgyr Federal Home Loan Bank Of New York Stock
FederalHomeLoanBankOfNewYorkStock
58000 usd
CY2023Q2 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
9777000 usd
CY2022Q2 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
7476000 usd
us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
27452000 usd
us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
21389000 usd
CY2023Q2 us-gaap Interest Expense Deposits
InterestExpenseDeposits
2648000 usd
CY2022Q2 us-gaap Interest Expense Deposits
InterestExpenseDeposits
420000 usd
us-gaap Interest Expense Deposits
InterestExpenseDeposits
6132000 usd
us-gaap Interest Expense Deposits
InterestExpenseDeposits
1286000 usd
CY2023Q2 us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
239000 usd
CY2022Q2 us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
92000 usd
us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
594000 usd
us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
323000 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
2887000 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
512000 usd
us-gaap Interest Expense
InterestExpense
6726000 usd
us-gaap Interest Expense
InterestExpense
1609000 usd
CY2023Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
6890000 usd
CY2022Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
6964000 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
20726000 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
19780000 usd
CY2023Q2 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
-81000 usd
CY2022Q2 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
205000 usd
us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
432000 usd
us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
376000 usd
CY2023Q2 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
6971000 usd
CY2022Q2 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
6759000 usd
us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
20294000 usd
us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
19404000 usd
CY2023Q2 mgyr Service Charge Income
ServiceChargeIncome
392000 usd
CY2022Q2 mgyr Service Charge Income
ServiceChargeIncome
284000 usd
mgyr Service Charge Income
ServiceChargeIncome
957000 usd
mgyr Service Charge Income
ServiceChargeIncome
860000 usd
CY2023Q2 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
92000 usd
CY2022Q2 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
94000 usd
us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
278000 usd
us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
275000 usd
CY2022Q2 mgyr Interest Rate Swap Fees
InterestRateSwapFees
76000 usd
mgyr Interest Rate Swap Fees
InterestRateSwapFees
57000 usd
mgyr Interest Rate Swap Fees
InterestRateSwapFees
76000 usd
CY2023Q2 us-gaap Other Operating Income
OtherOperatingIncome
34000 usd
CY2022Q2 us-gaap Other Operating Income
OtherOperatingIncome
21000 usd
us-gaap Other Operating Income
OtherOperatingIncome
75000 usd
us-gaap Other Operating Income
OtherOperatingIncome
67000 usd
CY2023Q2 us-gaap Gain Loss On Sale Of Loans And Leases
GainLossOnSaleOfLoansAndLeases
103000 usd
CY2022Q2 us-gaap Gain Loss On Sale Of Loans And Leases
GainLossOnSaleOfLoansAndLeases
134000 usd
us-gaap Gain Loss On Sale Of Loans And Leases
GainLossOnSaleOfLoansAndLeases
485000 usd
us-gaap Gain Loss On Sale Of Loans And Leases
GainLossOnSaleOfLoansAndLeases
553000 usd
CY2022Q2 us-gaap Debt Securities Gain Loss
DebtSecuritiesGainLoss
67000 usd
us-gaap Debt Securities Gain Loss
DebtSecuritiesGainLoss
67000 usd
CY2023Q2 us-gaap Noninterest Income
NoninterestIncome
621000 usd
CY2022Q2 us-gaap Noninterest Income
NoninterestIncome
676000 usd
us-gaap Noninterest Income
NoninterestIncome
1852000 usd
us-gaap Noninterest Income
NoninterestIncome
1898000 usd
CY2023Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
2966000 usd
CY2022Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
2701000 usd
us-gaap Labor And Related Expense
LaborAndRelatedExpense
8773000 usd
us-gaap Labor And Related Expense
LaborAndRelatedExpense
8096000 usd
CY2023Q2 us-gaap Occupancy Net
OccupancyNet
803000 usd
CY2022Q2 us-gaap Occupancy Net
OccupancyNet
750000 usd
us-gaap Occupancy Net
OccupancyNet
2355000 usd
us-gaap Occupancy Net
OccupancyNet
2255000 usd
CY2023Q2 us-gaap Professional Fees
ProfessionalFees
188000 usd
CY2022Q2 us-gaap Professional Fees
ProfessionalFees
198000 usd
us-gaap Professional Fees
ProfessionalFees
572000 usd
us-gaap Professional Fees
ProfessionalFees
856000 usd
CY2023Q2 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
148000 usd
CY2022Q2 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
136000 usd
us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
443000 usd
us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
409000 usd
CY2023Q2 us-gaap Business Development
BusinessDevelopment
101000 usd
CY2022Q2 us-gaap Business Development
BusinessDevelopment
143000 usd
us-gaap Business Development
BusinessDevelopment
344000 usd
us-gaap Business Development
BusinessDevelopment
353000 usd
CY2023Q2 us-gaap Loan Portfolio Expense
LoanPortfolioExpense
3000 usd
CY2022Q2 us-gaap Loan Portfolio Expense
LoanPortfolioExpense
6000 usd
us-gaap Loan Portfolio Expense
LoanPortfolioExpense
28000 usd
us-gaap Loan Portfolio Expense
LoanPortfolioExpense
54000 usd
CY2023Q2 us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
96000 usd
CY2022Q2 us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
55000 usd
us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
243000 usd
us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
161000 usd
CY2023Q2 mgyr Service Fees
ServiceFees
67000 usd
CY2022Q2 mgyr Service Fees
ServiceFees
2000 usd
mgyr Service Fees
ServiceFees
138000 usd
mgyr Service Fees
ServiceFees
86000 usd
CY2023Q2 us-gaap Other Noninterest Expense
OtherNoninterestExpense
514000 usd
CY2022Q2 us-gaap Other Noninterest Expense
OtherNoninterestExpense
441000 usd
us-gaap Other Noninterest Expense
OtherNoninterestExpense
1368000 usd
us-gaap Other Noninterest Expense
OtherNoninterestExpense
1293000 usd
CY2023Q2 us-gaap Noninterest Expense
NoninterestExpense
4886000 usd
CY2022Q2 us-gaap Noninterest Expense
NoninterestExpense
4432000 usd
us-gaap Noninterest Expense
NoninterestExpense
14264000 usd
us-gaap Noninterest Expense
NoninterestExpense
13563000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2706000 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3003000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
7882000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
7739000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
4520000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
101165000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
1918000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
788000 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
886000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2358000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2250000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
1918000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
2117000 usd
us-gaap Net Income Loss
NetIncomeLoss
5524000 usd
us-gaap Net Income Loss
NetIncomeLoss
5489000 usd
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.3
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.31
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.86
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.81
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.3
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.31
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.86
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.81
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6412536 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6799800 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6426978 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6797691 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6412536 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6799800 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6426978 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6797691 shares
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
1918000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
2117000 usd
us-gaap Net Income Loss
NetIncomeLoss
5524000 usd
us-gaap Net Income Loss
NetIncomeLoss
5489000 usd
CY2023Q2 mgyr Unrealized Gain Loss On Available For Sale Securities
UnrealizedGainLossOnAvailableForSaleSecurities
-137000 usd
CY2022Q2 mgyr Unrealized Gain Loss On Available For Sale Securities
UnrealizedGainLossOnAvailableForSaleSecurities
-490000 usd
mgyr Unrealized Gain Loss On Available For Sale Securities
UnrealizedGainLossOnAvailableForSaleSecurities
247000 usd
mgyr Unrealized Gain Loss On Available For Sale Securities
UnrealizedGainLossOnAvailableForSaleSecurities
-1285000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
-137000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
-490000 usd
us-gaap Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
247000 usd
us-gaap Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
-1285000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
-34000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
-120000 usd
us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
61000 usd
us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
-316000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-103000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-370000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
186000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-969000 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1815000 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1747000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
5710000 usd
CY2023Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.03
CY2023Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
192000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-103000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Employee Stock Ownership Plan
StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan
24000 usd
CY2023Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
112996 shares
CY2023Q2 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
216000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
161000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
102757000 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
98502000 usd
us-gaap Net Income Loss
NetIncomeLoss
5524000 usd
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.17
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
1115000 usd
us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
186000 usd
us-gaap Stock Issued During Period Value Employee Stock Ownership Plan
StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan
98000 usd
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
112996 shares
us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
940000 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
502000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
102757000 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
99398000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
2117000 usd
CY2022Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.03
CY2022Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
204000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-370000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Employee Stock Ownership Plan
StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan
39000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
100980000 usd
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
97641000 usd
us-gaap Net Income Loss
NetIncomeLoss
5489000 usd
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.18
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
1223000 usd
us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-969000 usd
mgyr Purchase Of Treasury Stock Value
PurchaseOfTreasuryStockValue
-98000 usd
us-gaap Stock Issued During Period Value Employee Stock Ownership Plan
StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan
140000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
100980000 usd
us-gaap Net Income Loss
NetIncomeLoss
5524000 usd
us-gaap Net Income Loss
NetIncomeLoss
5489000 usd
us-gaap Depreciation
Depreciation
628000 usd
us-gaap Depreciation
Depreciation
627000 usd
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-112000 usd
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-148000 usd
us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
432000 usd
us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
376000 usd
us-gaap Increase Decrease In Assets Held For Sale
IncreaseDecreaseInAssetsHeldForSale
5450000 usd
us-gaap Increase Decrease In Assets Held For Sale
IncreaseDecreaseInAssetsHeldForSale
4903000 usd
mgyr Proceeds From Sales Of Loans Receivable
ProceedsFromSalesOfLoansReceivable
5935000 usd
mgyr Proceeds From Sales Of Loans Receivable
ProceedsFromSalesOfLoansReceivable
5456000 usd
us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
485000 usd
us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
553000 usd
us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
67000 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
9000 usd
mgyr Esop Compensation Expense
EsopCompensationExpense
98000 usd
mgyr Esop Compensation Expense
EsopCompensationExpense
140000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
502000 usd
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-237000 usd
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
86000 usd
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
665000 usd
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
17000 usd
mgyr Increase In Surrender Value Bank Owned Life Insurance
IncreaseInSurrenderValueBankOwnedLifeInsurance
278000 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-29000 usd
mgyr Increase In Surrender Value Bank Owned Life Insurance
IncreaseInSurrenderValueBankOwnedLifeInsurance
275000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
57000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1015000 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
128000 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-1625000 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
1119000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
4553000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
6582000 usd
mgyr Net Increase Decrease In Loans Receivable
NetIncreaseDecreaseInLoansReceivable
-60547000 usd
mgyr Net Increase Decrease In Loans Receivable
NetIncreaseDecreaseInLoansReceivable
-31731000 usd
us-gaap Payments To Acquire Loans Receivable
PaymentsToAcquireLoansReceivable
13350000 usd
us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
39535000 usd
us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
7858000 usd
us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
5886000 usd
mgyr Principal Repayments On Investment Securities Available For Sale
PrincipalRepaymentsOnInvestmentSecuritiesAvailableForSale
698000 usd
mgyr Principal Repayments On Investment Securities Available For Sale
PrincipalRepaymentsOnInvestmentSecuritiesAvailableForSale
1523000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3000000 usd
mgyr Sales Of Payments For Property And Equipment
SalesOfPaymentsForPropertyAndEquipment
241000 usd
mgyr Sales Of Payments For Property And Equipment
SalesOfPaymentsForPropertyAndEquipment
246000 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
19000 usd
mgyr Investment In Other Real Estate
InvestmentInOtherRealEstate
11000 usd
mgyr Investment In Other Real Estate
InvestmentInOtherRealEstate
12000 usd
us-gaap Payments For Proceeds From Other Real Estate Partnerships
PaymentsForProceedsFromOtherRealEstatePartnerships
-434000 usd
us-gaap Payments To Acquire Federal Home Loan Bank Stock
PaymentsToAcquireFederalHomeLoanBankStock
5747000 usd
us-gaap Payments To Acquire Federal Home Loan Bank Stock
PaymentsToAcquireFederalHomeLoanBankStock
56000 usd
us-gaap Proceeds From Sale Of Federal Home Loan Bank Stock
ProceedsFromSaleOfFederalHomeLoanBankStock
4143000 usd
us-gaap Proceeds From Sale Of Federal Home Loan Bank Stock
ProceedsFromSaleOfFederalHomeLoanBankStock
363000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-67178000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-66374000 usd
us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
25739000 usd
us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
20007000 usd
us-gaap Origination Of Loan To Purchase Common Stock
OriginationOfLoanToPurchaseCommonStock
98000 usd
mgyr Net Increase In Escrowed Funds
NetIncreaseInEscrowedFunds
500000 usd
mgyr Net Increase In Escrowed Funds
NetIncreaseInEscrowedFunds
298000 usd
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
17000000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
3091000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
8072000 usd
us-gaap Proceeds From Other Short Term Debt
ProceedsFromOtherShortTermDebt
16000000 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
1115000 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
1223000 usd
mgyr Purchase Treasury Stock
PurchaseTreasuryStock
940000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
54093000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
10912000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-8532000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-48880000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
30936000 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
75201000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
22404000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
26321000 usd
us-gaap Interest Paid Net
InterestPaidNet
6597000 usd
us-gaap Interest Paid Net
InterestPaidNet
1638000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
2800000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
2180000 usd
us-gaap Allowance For Loan And Lease Losses Loans Acquired
AllowanceForLoanAndLeaseLossesLoansAcquired
8400000 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1918000 usd
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
2117000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
5524000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
5489000 usd
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6412536 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6799800 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6426978 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6797691 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6412536 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6799800 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6426978 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6797691 shares
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.3
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.31
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.86
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.81
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.3
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.31
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.86
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.81
CY2023Q2 us-gaap Excess Stock Shares Issued
ExcessStockSharesIssued
293200 shares
CY2023Q2 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
12.58
us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
155400 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Per Share Weighted Average Price Of Shares Purchased
ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased
12.63
CY2022Q3 mgyr Equity Compensation Shares
EquityCompensationShares
547400 shares
us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
293200 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
293200 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
12.58
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P10Y
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
293200 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
12.58
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P9Y2M12D
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
156400 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
12.63
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
1000 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
12.7
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
155400 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
12.63
CY2023Q2 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
63000000 usd
CY2023Q2 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
98000000 usd
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
195000000 usd
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
307000000 usd
CY2022Q4 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
354891 shares
CY2022Q4 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
12.9
CY2022Q4 us-gaap Common Stock Other Shares Outstanding
CommonStockOtherSharesOutstanding
337146 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Shares To Be Repurchased Next Year
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesToBeRepurchasedNextYear
75362 shares
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
261784 shares
CY2023Q2 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
337146 shares
CY2023Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
429253 shares
CY2021 us-gaap Stock Issued During Period Shares Other
StockIssuedDuringPeriodSharesOther
312800 shares
CY2021 us-gaap Stock Issued1
StockIssued1
3400000 usd
CY2021Q3 us-gaap Share Price
SharePrice
10.77
CY2023Q1 us-gaap Derivative Variable Interest Rate
DerivativeVariableInterestRate
0.075 pure
CY2023Q1 mgyr Principal And Interest Payable Term
PrincipalAndInterestPayableTerm
P30Y
mgyr Shares Allocated To Participants
SharesAllocatedToParticipants
22487 shares
mgyr Shares Unallocated In Suspenses
SharesUnallocatedInSuspenses
290313 shares
mgyr Aggregate Fair Value
AggregateFairValue
3000000 usd
us-gaap Contribution Of Property
ContributionOfProperty
98000000 usd
us-gaap Contribution Of Property
ContributionOfProperty
140000000 usd
CY2023Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-137000 usd
CY2023Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
34000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
-103000 usd
CY2022Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-490000 usd
CY2022Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
120000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
-370000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
-137000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
34000 usd
CY2023Q2 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
-103000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
-490000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
120000 usd
CY2022Q2 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
-370000 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
247000 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-61000 usd
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
186000 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-1285000 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
316000 usd
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
-969000 usd
us-gaap Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
247000 usd
us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
-61000 usd
us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
186000 usd
us-gaap Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
-1285000 usd
us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
316000 usd
us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
-969000 usd
CY2023Q2 us-gaap Derivative Assets Liabilities At Fair Value Net
DerivativeAssetsLiabilitiesAtFairValueNet
2383000 usd
CY2023Q2 mgyr Assets Fair Value Disclosure1
AssetsFairValueDisclosure1
11117000 usd
CY2023Q2 us-gaap Derivative Liabilities
DerivativeLiabilities
2383000 usd
CY2023Q2 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
2383000 usd
CY2022Q3 us-gaap Derivative Assets Liabilities At Fair Value Net
DerivativeAssetsLiabilitiesAtFairValueNet
2487000 usd
CY2022Q3 mgyr Assets Fair Value Disclosure1
AssetsFairValueDisclosure1
11716000 usd
CY2022Q3 us-gaap Derivative Liabilities
DerivativeLiabilities
2487000 usd
CY2022Q3 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
2487000 usd
us-gaap Loans And Leases Receivable Impaired Interest Income Recognized Change In Present Value Attributable To Passage Of Time
LoansAndLeasesReceivableImpairedInterestIncomeRecognizedChangeInPresentValueAttributableToPassageOfTime
777000 usd
CY2023Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
777000 usd
CY2022 us-gaap Loans And Leases Receivable Impaired Interest Income Recognized Change In Present Value Attributable To Passage Of Time
LoansAndLeasesReceivableImpairedInterestIncomeRecognizedChangeInPresentValueAttributableToPassageOfTime
5659000 usd
CY2022Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
5659000 usd
CY2023Q2 mgyr Available For Sales Debt Securities Amortized Cost Basis
AvailableForSalesDebtSecuritiesAmortizedCostBasis
10405000 usd
CY2023Q2 mgyr Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax2
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax2
1671000 usd
CY2023Q2 mgyr Available For Sale Securities1
AvailableForSaleSecurities1
8734000 usd
CY2023Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
83720000 usd
CY2023Q2 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Gain
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
3000 usd
CY2023Q2 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Loss
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
10386000 usd
CY2023Q2 mgyr Held To Maturity Securities Fair Values
HeldToMaturitySecuritiesFairValues
73337000 usd
CY2022Q3 mgyr Available For Sales Debt Securities Amortized Cost Basis
AvailableForSalesDebtSecuritiesAmortizedCostBasis
11147000 usd
CY2022Q3 mgyr Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax2
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax2
1918000 usd
CY2022Q3 mgyr Available For Sale Securities1
AvailableForSaleSecurities1
9229000 usd
CY2022Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
91646000 usd
CY2022Q3 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Gain
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
12000 usd
CY2022Q3 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Loss
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
11744000 usd
CY2022Q3 mgyr Held To Maturity Securities Fair Values
HeldToMaturitySecuritiesFairValues
79914000 usd
CY2023Q2 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
12800000 usd
CY2023Q2 mgyr Fair Value1
FairValue1
81764000 usd
CY2023Q2 mgyr Unrealized Losses
UnrealizedLosses
12057000 usd
CY2022Q3 mgyr Fair Value1
FairValue1
88864000 usd
CY2022Q3 mgyr Unrealized Losses
UnrealizedLosses
13662000 usd
CY2023Q2 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
702530000 usd
CY2022Q3 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
628904000 usd
CY2023Q2 mgyr Loans And Leases Receivable Deferred Cost
LoansAndLeasesReceivableDeferredCost
-844000 usd
CY2022Q3 mgyr Loans And Leases Receivable Deferred Cost
LoansAndLeasesReceivableDeferredCost
-628000 usd
us-gaap Allowance For Loan And Lease Losses Adjustments Net
AllowanceForLoanAndLeaseLossesAdjustmentsNet
8378000 usd
CY2022 us-gaap Allowance For Loan And Lease Losses Adjustments Net
AllowanceForLoanAndLeaseLossesAdjustmentsNet
8433000 usd
CY2023Q2 us-gaap Loans And Leases Receivable Deferred Income
LoansAndLeasesReceivableDeferredIncome
693308000 usd
CY2022Q3 us-gaap Loans And Leases Receivable Deferred Income
LoansAndLeasesReceivableDeferredIncome
619843000 usd
CY2022Q3 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
8433000 usd
CY2022Q4 us-gaap Provision For Other Losses
ProvisionForOtherLosses
317000 usd
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
8750000 usd
CY2023Q1 mgyr Chargeoffs
Chargeoffs
-102000 usd
CY2023Q1 us-gaap Provision For Other Losses
ProvisionForOtherLosses
196000 usd
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
8844000 usd
CY2023Q2 mgyr Chargeoffs
Chargeoffs
-386000 usd
CY2023Q2 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
1000 usd
CY2023Q2 us-gaap Impaired Financing Receivable With No Related Allowance Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment
3851000 usd
CY2023Q2 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
3851000 usd
CY2023Q2 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
3916000 usd
CY2022Q3 us-gaap Impaired Financing Receivable With Related Allowance Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment
2835000 usd
CY2022Q3 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
114000 usd
CY2022Q3 us-gaap Impaired Financing Receivable With No Related Allowance Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment
2824000 usd
CY2022Q3 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
5659000 usd
CY2022Q3 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
5724000 usd
us-gaap Loans And Leases Receivable Related Parties Proceeds
LoansAndLeasesReceivableRelatedPartiesProceeds
106000 usd
us-gaap Loans And Leases Receivable Related Parties Proceeds
LoansAndLeasesReceivableRelatedPartiesProceeds
373000 usd
CY2023Q2 us-gaap Loans And Leases Receivable Impaired Troubled Debt Interest Income
LoansAndLeasesReceivableImpairedTroubledDebtInterestIncome
5067000 usd
us-gaap Loans And Leases Receivable Impaired Troubled Debt Interest Income
LoansAndLeasesReceivableImpairedTroubledDebtInterestIncome
5326000 usd
CY2023Q2 us-gaap Impaired Financing Receivable With Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod
37000 usd
us-gaap Impaired Financing Receivable With Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod
108000 usd
CY2022Q2 us-gaap Loans And Leases Receivable Impaired Troubled Debt Interest Income
LoansAndLeasesReceivableImpairedTroubledDebtInterestIncome
8114000 usd
us-gaap Loans And Leases Receivable Impaired Troubled Debt Interest Income
LoansAndLeasesReceivableImpairedTroubledDebtInterestIncome
8911000 usd
CY2022Q2 us-gaap Impaired Financing Receivable With Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod
46000 usd
us-gaap Impaired Financing Receivable With Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod
139000 usd
mgyr Commercial Relationship Amount
CommercialRelationshipAmount
500000 usd
mgyr Criticized Relationship Amount
CriticizedRelationshipAmount
250000 usd
CY2023Q2 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
702530000 usd
CY2022Q3 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
628904000 usd
CY2023Q2 mgyr Loans Receivable Current
LoansReceivableCurrent
698465000 usd
CY2023Q2 mgyr Loans Receivable Past Due
LoansReceivablePastDue
4065000 usd
CY2023Q2 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
3560000 usd
CY2023Q2 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
702530000 usd
CY2022Q3 mgyr Loans Receivable Current
LoansReceivableCurrent
625208000 usd
CY2022Q3 mgyr Loans Receivable Past Due
LoansReceivablePastDue
3696000 usd
CY2022Q3 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
2835000 usd
CY2022Q3 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
628904000 usd
CY2023Q2 us-gaap Provision For Other Losses
ProvisionForOtherLosses
-81000 usd
CY2023Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
8378000 usd
CY2021Q3 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
8075000 usd
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
53000 usd
CY2021Q4 us-gaap Provision For Other Losses
ProvisionForOtherLosses
100000 usd
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
8228000 usd
CY2022Q1 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
1000 usd
CY2022Q1 us-gaap Provision For Other Losses
ProvisionForOtherLosses
71000 usd
CY2022Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
8300000 usd
CY2022Q2 us-gaap Provision For Other Losses
ProvisionForOtherLosses
205000 usd
CY2022Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
8505000 usd
us-gaap Loans And Leases Receivable Related Parties Period Increase Decrease
LoansAndLeasesReceivableRelatedPartiesPeriodIncreaseDecrease
106000 usd
mgyr Number Of Loans
NumberOfLoans
1 pure
mgyr Investment Before Tdr Modification
InvestmentBeforeTDRModification
97000 usd
mgyr Investment After Tdr Modification
InvestmentAfterTDRModification
106000 usd
us-gaap Loans And Leases Receivable Related Parties Period Increase Decrease
LoansAndLeasesReceivableRelatedPartiesPeriodIncreaseDecrease
373000 usd
CY2022Q2 mgyr Number Of Loans
NumberOfLoans
1 pure
CY2022Q2 mgyr Investment Before Tdr Modification
InvestmentBeforeTDRModification
112000 usd
CY2022Q2 mgyr Investment After Tdr Modification
InvestmentAfterTDRModification
124000 usd
mgyr Number Of Loans
NumberOfLoans
2 pure
mgyr Investment Before Tdr Modification
InvestmentBeforeTDRModification
330000 usd
mgyr Investment After Tdr Modification
InvestmentAfterTDRModification
373000 usd
CY2023Q2 us-gaap Demand Deposit Accounts
DemandDepositAccounts
182924000 usd
CY2022Q3 us-gaap Demand Deposit Accounts
DemandDepositAccounts
182417000 usd
CY2023Q2 us-gaap Deposits Savings Deposits
DepositsSavingsDeposits
65470000 usd
CY2022Q3 us-gaap Deposits Savings Deposits
DepositsSavingsDeposits
81850000 usd
CY2023Q2 us-gaap Deposits Negotiable Order Of Withdrawal Now
DepositsNegotiableOrderOfWithdrawalNOW
93833000 usd
CY2022Q3 us-gaap Deposits Negotiable Order Of Withdrawal Now
DepositsNegotiableOrderOfWithdrawalNOW
98643000 usd
CY2023Q2 us-gaap Deposits Money Market Deposits
DepositsMoneyMarketDeposits
247870000 usd
CY2022Q3 us-gaap Deposits Money Market Deposits
DepositsMoneyMarketDeposits
222214000 usd
CY2023Q2 mgyr Certificates Of Deposit
CertificatesOfDeposit
91528000 usd
CY2022Q3 mgyr Certificates Of Deposit
CertificatesOfDeposit
69929000 usd
CY2023Q2 mgyr Retirement Deposits
RetirementDeposits
11847000 usd
CY2022Q3 mgyr Retirement Deposits
RetirementDeposits
12680000 usd
CY2023Q2 us-gaap Deposits Assets Current
DepositsAssetsCurrent
693472000 usd
CY2022Q3 us-gaap Deposits Assets Current
DepositsAssetsCurrent
667733000 usd
CY2023Q2 us-gaap Deposits Assets
DepositsAssets
18800000 usd
CY2023Q2 us-gaap Interest Bearing Domestic Deposit Certificates Of Deposits
InterestBearingDomesticDepositCertificatesOfDeposits
15500000 usd
CY2022Q3 us-gaap Deposits Assets
DepositsAssets
6000000 usd
CY2022Q3 us-gaap Interest Bearing Domestic Deposit Certificates Of Deposits
InterestBearingDomesticDepositCertificatesOfDeposits
14600000 usd
us-gaap Proceeds From Payments For In Interest Bearing Deposits In Banks
ProceedsFromPaymentsForInInterestBearingDepositsInBanks
250000 usd
us-gaap Interest Expense Now Accounts Money Market Accounts And Savings Deposits
InterestExpenseNOWAccountsMoneyMarketAccountsAndSavingsDeposits
250000 usd
us-gaap Interest Expense Demand Deposit Accounts
InterestExpenseDemandDepositAccounts
388500000 usd
CY2022 us-gaap Interest Expense Demand Deposit Accounts
InterestExpenseDemandDepositAccounts
399900000 usd
us-gaap Payments For Deposits
PaymentsForDeposits
95400000 usd
CY2023Q2 us-gaap Time Deposits At Or Above Fdic Insurance Limit
TimeDepositsAtOrAboveFDICInsuranceLimit
250000 usd
CY2022Q3 us-gaap Time Deposits At Or Above Fdic Insurance Limit
TimeDepositsAtOrAboveFDICInsuranceLimit
129400000 usd
CY2023Q2 us-gaap Deposits Domestic
DepositsDomestic
200900000 usd
CY2022Q3 us-gaap Deposits Domestic
DepositsDomestic
140600000 usd
CY2023Q2 us-gaap Deposits With Other Federal Home Loan Banks
DepositsWithOtherFederalHomeLoanBanks
194400000 usd
CY2022Q3 us-gaap Deposits With Other Federal Home Loan Banks
DepositsWithOtherFederalHomeLoanBanks
139300000 usd
us-gaap Proceeds From Mortgage Deposits
ProceedsFromMortgageDeposits
250000 usd
CY2023Q2 mgyr Financial Instruments Contract Amounts
FinancialInstrumentsContractAmounts
103380000 usd
CY2022Q3 mgyr Financial Instruments Contract Amounts
FinancialInstrumentsContractAmounts
127028000 usd
CY2023Q2 mgyr Interest Rate Swap Fees
InterestRateSwapFees
usd
CY2023Q2 us-gaap Debt Securities Gain Loss
DebtSecuritiesGainLoss
usd
us-gaap Debt Securities Gain Loss
DebtSecuritiesGainLoss
usd
us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
usd
us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
usd
us-gaap Share Based Compensation
ShareBasedCompensation
usd
us-gaap Payments To Acquire Loans Receivable
PaymentsToAcquireLoansReceivable
usd
us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
usd
us-gaap Payments For Proceeds From Other Real Estate Partnerships
PaymentsForProceedsFromOtherRealEstatePartnerships
usd
us-gaap Origination Of Loan To Purchase Common Stock
OriginationOfLoanToPurchaseCommonStock
usd
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
usd
us-gaap Proceeds From Other Short Term Debt
ProceedsFromOtherShortTermDebt
usd
mgyr Purchase Treasury Stock
PurchaseTreasuryStock
usd
CY2022Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
mgyr Weighted Averages Remaining Contractual Life Granted
WeightedAveragesRemainingContractualLifeGranted
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
usd
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
mgyr Sharebased Compensation Arrangement By Sharebased Payment Exercised Aggregate Intrinsic Value
SharebasedCompensationArrangementBySharebasedPaymentExercisedAggregateIntrinsicValue
usd
mgyr Weighted Averages Remaining Contractual Life Forfeited
WeightedAveragesRemainingContractualLifeForfeited
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
mgyr Sharebased Compensation Arrangement By Sharebased Payment Forfeited Aggregate Intrinsic Value
SharebasedCompensationArrangementBySharebasedPaymentForfeitedAggregateIntrinsicValue
usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
mgyr Weighted Average Remaining Contractual Life Expired
WeightedAverageRemainingContractualLifeExpired
mgyr Sharebased Compensation Arrangement By Sharebased Payment Expired Aggregate Intrinsic Value
SharebasedCompensationArrangementBySharebasedPaymentExpiredAggregateIntrinsicValue
usd
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
usd
CY2023Q2 mgyr Weighted Average Exercise Price Exercisable
WeightedAverageExercisePriceExercisable
shares
CY2023Q2 mgyr Weighted Average Remaining Contractual Life Exercisable
WeightedAverageRemainingContractualLifeExercisable
us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
mgyr Sharebased Compensation Arrangement By Sharebased Payment Exercisable Aggregate Intrinsic Value
SharebasedCompensationArrangementBySharebasedPaymentExercisableAggregateIntrinsicValue
usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
shares
CY2023Q2 mgyr Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax1
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax1
usd
CY2022Q3 mgyr Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax1
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax1
usd
CY2023Q2 us-gaap Impaired Financing Receivable With Related Allowance Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment
usd
CY2023Q2 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
usd
CY2022Q4 mgyr Chargeoffs
Chargeoffs
usd
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
usd
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
usd
CY2021Q4 mgyr Chargeoffs
Chargeoffs
usd
CY2022Q1 mgyr Chargeoffs
Chargeoffs
usd
CY2022Q2 mgyr Chargeoffs
Chargeoffs
usd
CY2022Q2 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
usd
CY2023Q2 mgyr Number Of Loans
NumberOfLoans
pure
CY2023Q2 mgyr Investment Before Tdr Modification
InvestmentBeforeTDRModification
usd
CY2023Q2 mgyr Investment After Tdr Modification
InvestmentAfterTDRModification
usd
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001337068

Files In Submission

Name View Source Status
0001174947-23-001034-index-headers.html Edgar Link pending
0001174947-23-001034-index.html Edgar Link pending
0001174947-23-001034.txt Edgar Link pending
0001174947-23-001034-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
mgyr-20230630.htm Edgar Link pending
mgyr-20230630.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
mgyr-20230630_cal.xml Edgar Link unprocessable
mgyr-20230630_lab.xml Edgar Link unprocessable
mgyr-20230630_pre.xml Edgar Link unprocessable
mgyr-20230630_htm.xml Edgar Link completed
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
mgyr-20230630_def.xml Edgar Link unprocessable